Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 3, 2018 - The FDA approved Exeltis’ Nuvessa (metronidazole) vaginal gel 1.3%, for the treatment of bacterial vaginosis in females 12 years of age and older.
Return to publications